An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation

BACKGROUND: Corticosteroids and calcineurin inhibitors (CNIs) are included in renal transplantation immunosuppressive protocols around the world. Well-known side effects are associated with the use of these drugs, including new onset of diabetes after transplantation (NODAT). Long-term patient survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekberg, Jana, Ekberg, Henrik, Jespersen, Bente, Källen, Ragnar, Skov, Karin, Olausson, Michael, Mjörnstedt, Lars, Lindnér, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067097/
https://www.ncbi.nlm.nih.gov/pubmed/24959347
http://dx.doi.org/10.1186/2047-1440-3-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067097/
https://www.ncbi.nlm.nih.gov/pubmed/24959347
http://dx.doi.org/10.1186/2047-1440-3-12

Ejemplares similares